SCHEMBL7363727

SCHEMBL7363727

CC(CCS(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1)N(O)C=O

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 17/20 0.48
MMP9 P14780 17/20 0.48
MMP1 P03956 6/20 0.48
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
MMP14 P50281 2/20 0.43
MMP13 P45452 2/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7360562 0.89 MMP2 (0.54) MMP2MMP9MMP1MEN1ALDH1A1
SCHEMBL7360556 0.89 MMP2 (0.54) MMP2MMP9MMP1MEN1ALDH1A1
SCHEMBL7539103 0.87 MMP2 (0.65) MMP2MMP9MMP1
SCHEMBL7539094 0.87 MMP2 (0.65) MMP2MMP9MMP1
SCHEMBL7916943 0.75 MMP2 (0.69) MMP2MMP9MMP1
SCHEMBL7916947 0.75 MMP2 (0.69) MMP2MMP9MMP1
SCHEMBL7447089 0.75 MMP9 (0.58) MMP2MMP9MMP1MMP13
SCHEMBL10021363 0.75 MMP9 (0.74) MMP2MMP9MMP1
SCHEMBL7363730 0.74 ALDH1A1 (0.48) MMP2MMP9MMP1MEN1ALDH1A1
SCHEMBL7673831 0.71 MMP2 (0.83) MMP2MMP9MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000044712-A1 N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LABORATORIES (US) 2000-08-03 WO claimed
US-6235786-B1 RHEUMATIC DISORDERS; BONE DISORDERS; ORAL DISEASES; ANTIULCER AGENTS; ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-22 US disclosed
WO-2000044712-A1 N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LABORATORIES (US) 2000-08-03 WO disclosed